4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-25-021346
CHIEF MEDICAL OFFICER sold 29,325 shares at $32.55 ($954,529)
- CHIEF MEDICAL OFFICER acquired 29,325 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Paolini John F. CHIEF MEDICAL OFFICER | 2025-08-06 | Option exercise 10b5-1 | +29,325 | $3.80 | $111,435 | 86,728 | D |
| Paolini John F. CHIEF MEDICAL OFFICER | 2025-08-06 | Sale 10b5-1 | −29,325 | $32.55 | $954,529 | 57,403 | D |
| Derivatives | |||||||
| Paolini John F. CHIEF MEDICAL OFFICER | 2025-08-06 | Option exercise · Share Option 10b5-1 | −29,325 | 36,542 | D | ||
| Open-market sales · 29,325 sh · avg $32.55 · $954,529 | |||||||
Loading xslF345X05/form4-08082025_040802.xml…